These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 11740718
1. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. Clin Infect Dis; 2002 Jan 15; 34(2):277-84. PubMed ID: 11740718 [Abstract] [Full Text] [Related]
2. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, Goldman M, Thomas CJ, Gutsch HM, Moskovitz B, Dismukes WE, Kauffman CA. Clin Infect Dis; 1999 May 15; 28(5):1049-56. PubMed ID: 10452633 [Abstract] [Full Text] [Related]
3. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. N Engl J Med; 1998 Dec 10; 339(24):1739-43. PubMed ID: 9845708 [Abstract] [Full Text] [Related]
4. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W. Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365 [Abstract] [Full Text] [Related]
6. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, AIDS Clinical Trials Group Study Team 323, Mycoses Study Group Study Team 40. Clin Infect Dis; 2005 Nov 15; 41(10):1473-80. PubMed ID: 16231260 [Abstract] [Full Text] [Related]
7. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection. Manfredi R, Mastroianni A, Coronado OV, Chiodo F. Arch Intern Med; 1997 Jan 13; 157(1):64-9. PubMed ID: 8996042 [Abstract] [Full Text] [Related]
10. Itraconazole to prevent fungal infections in chronic granulomatous disease. Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, Eisenstein EM, Turner ML, DeCarlo ES, Starling JM, Holland SM. N Engl J Med; 2003 Jun 12; 348(24):2416-22. PubMed ID: 12802027 [Abstract] [Full Text] [Related]
11. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany. J Antimicrob Chemother; 2006 Feb 12; 57(2):317-25. PubMed ID: 16339606 [Abstract] [Full Text] [Related]
12. Current approach to the acute management of cryptococcal infections. Powderly WG. J Infect; 2000 Jul 12; 41(1):18-22. PubMed ID: 11041709 [No Abstract] [Full Text] [Related]
13. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W. Clin Infect Dis; 2000 Feb 12; 30(2):300-5. PubMed ID: 10671332 [Abstract] [Full Text] [Related]
15. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART. Chaiwarith R, Charoenyos N, Sirisanthana T, Supparatpinyo K. AIDS; 2007 Jan 30; 21(3):365-7. PubMed ID: 17255744 [Abstract] [Full Text] [Related]
16. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H. N Engl J Med; 1995 Mar 16; 332(11):700-5. PubMed ID: 7854376 [Abstract] [Full Text] [Related]
18. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Baosoung V, Uthammachai C, Chaimongkol B, Sirisanthana T. J Med Assoc Thai; 1992 Dec 16; 75(12):688-91. PubMed ID: 1339213 [Abstract] [Full Text] [Related]
19. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. Glasmacher A, Prentice A, Gorschlüter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG. J Clin Oncol; 2003 Dec 15; 21(24):4615-26. PubMed ID: 14673051 [Abstract] [Full Text] [Related]
20. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC. Clin Microbiol Infect; 2006 Apr 15; 12(4):381-8. PubMed ID: 16524416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]